BRPI0809667A2 - COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND - Google Patents
COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUNDInfo
- Publication number
- BRPI0809667A2 BRPI0809667A2 BRPI0809667-8A2A BRPI0809667A BRPI0809667A2 BR PI0809667 A2 BRPI0809667 A2 BR PI0809667A2 BR PI0809667 A BRPI0809667 A BR PI0809667A BR PI0809667 A2 BRPI0809667 A2 BR PI0809667A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- composition containing
- medicinal product
- medicinal
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2007051292 | 2007-04-11 | ||
| IB2008050746 | 2008-02-29 | ||
| PCT/IB2008/051356 WO2008126024A2 (en) | 2007-04-11 | 2008-04-10 | Oxazolidinone antibiotic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0809667A2 true BRPI0809667A2 (en) | 2014-10-07 |
Family
ID=39722506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0809667-8A2A BRPI0809667A2 (en) | 2007-04-11 | 2008-04-10 | COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8114867B2 (en) |
| EP (1) | EP2146987B1 (en) |
| JP (1) | JP5363457B2 (en) |
| KR (1) | KR101563752B1 (en) |
| CN (1) | CN101657450B (en) |
| AR (1) | AR066012A1 (en) |
| AU (1) | AU2008238894B2 (en) |
| BR (1) | BRPI0809667A2 (en) |
| CA (1) | CA2679069C (en) |
| CL (1) | CL2008001003A1 (en) |
| ES (1) | ES2560870T3 (en) |
| MX (1) | MX2009010641A (en) |
| PL (1) | PL2146987T3 (en) |
| RU (1) | RU2506263C2 (en) |
| TW (1) | TWI415614B (en) |
| WO (1) | WO2008126024A2 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2492169C2 (en) | 2007-12-18 | 2013-09-10 | Актелион Фармасьютиклз Лтд | 5-aminocyclylmethyloxazolidin-2-one derivatives |
| ES2411930T3 (en) | 2008-02-20 | 2013-07-09 | Actelion Pharmaceuticals Ltd. | Azatricyclic antibiotic compounds |
| JP5404652B2 (en) | 2008-02-22 | 2014-02-05 | アクテリオン ファーマシューティカルズ リミテッド | Oxazolidinone derivatives |
| EP2321307B1 (en) * | 2008-08-04 | 2012-12-19 | Actelion Pharmaceuticals Ltd. | Tricyclic alkylaminomethyloxazolidinone derivatives |
| KR101294962B1 (en) | 2008-10-07 | 2013-08-12 | 액테리온 파마슈티칼 리미티드 | tricyclic oxazolidinone antibiotic compounds |
| CA2738775A1 (en) * | 2008-10-10 | 2010-04-15 | Actelion Pharmaceuticals Ltd | 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
| CN102232078B (en) | 2008-12-12 | 2014-07-16 | 埃科特莱茵药品有限公司 | 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives |
| EP2509997B1 (en) * | 2009-12-07 | 2017-08-30 | i2 Pharmaceuticals, Inc. | Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties |
| EP2377850A1 (en) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
| US8952010B2 (en) | 2011-02-07 | 2015-02-10 | Daiichi Sankyo Company, Limited | Amino group-containing pyrrolidinone derivative |
| CA2842885A1 (en) | 2011-08-11 | 2013-02-14 | Actelion Pharmaceuticals Ltd | Quinazoline-2,4-dione derivatives |
| JP6030146B2 (en) * | 2011-11-08 | 2016-11-24 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | 2-Oxo-oxazolidine-3,5-diyl antibiotic derivative |
| EP2785721A1 (en) | 2011-11-30 | 2014-10-08 | Actelion Pharmaceuticals Ltd. | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| WO2014024056A1 (en) | 2012-08-06 | 2014-02-13 | Daiichi Sankyo Company, Limited | Pyrrolidine derivatives with antibacterial properties |
| WO2014026928A1 (en) * | 2012-08-17 | 2014-02-20 | Basf Se | Process for manufacturing benzoxazinones |
| EA029361B1 (en) | 2013-04-16 | 2018-03-30 | Идорсиа Фармасьютиклз Лтд | Antibacterial biaromatic derivatives |
| AR102256A1 (en) * | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH REPLACEMENT OF AMINOALCOXI |
| EP3414246A1 (en) * | 2016-02-08 | 2018-12-19 | Redx Pharma PLC | Antibacterial compounds |
| US10487093B2 (en) | 2016-02-08 | 2019-11-26 | Redx Pharma Plc | Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds |
| GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
| GB2550437B (en) | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
| TW201833120A (en) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | Aryloxazolidinone antibiotic compound |
| EP3634968B1 (en) * | 2017-06-08 | 2023-01-25 | Bugworks Research, Inc. | Heterocyclic compounds useful as anti-bacterial agents and method for production thereof |
| WO2019106693A1 (en) * | 2017-11-29 | 2019-06-06 | Bugworks Research India Pvt Ltd | Anti-bacterial heterocyclic compounds and their synthesis |
| PT3774790T (en) * | 2018-03-28 | 2023-04-24 | Bugworks Res Inc | Oxazolidinone antibiotic compounds and process of preparation |
| CN117532894B (en) * | 2023-12-05 | 2024-06-14 | 东莞美泰电子有限公司 | PU leather hot-pressing leather pasting technology for protecting parts |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996033195A1 (en) | 1995-04-21 | 1996-10-24 | Shinnippon Pharmaceutical Inc. | FUSED IMIDAZO[1,2-a]PYRIDINES |
| CA2228647A1 (en) * | 1995-09-01 | 1997-03-13 | Pharmacia & Upjohn Company | Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| CA2331735A1 (en) | 1998-05-08 | 1999-11-18 | Smithkline Beecham P.L.C. | Phenylurea and phenylthio urea derivatives |
| DE60011570T2 (en) | 1999-01-07 | 2004-11-25 | Wyeth | ARYLPIPERAZINYL-CYCLOHEXYL INDOLDER DERIVATIVES FOR TREATING DEPRESSIONS |
| GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| EP1400519B1 (en) | 1999-06-28 | 2007-03-07 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| NZ523749A (en) | 2000-07-26 | 2005-03-24 | Smithkline Beecham P | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| GB0031086D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
| TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| EP1551829B1 (en) * | 2002-10-10 | 2010-04-07 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Novel compounds with antibacterial activity |
| ATE411312T1 (en) * | 2002-12-04 | 2008-10-15 | Glaxo Group Ltd | QUINOLINES AND NITROGEN-CONTAINING DERIVATIVES THEREOF AND THEIR USE AS ANTIBACTERIAL AGENTS |
| AR042486A1 (en) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | QUINOLINE AND NAFTIRIDINE COMPOSITE HALOSUSTITUDED IN POSITION 3, PROCEDURE TO PREPARE THE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE SUCH COMPOSITION. |
| DE10316081A1 (en) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | New compounds with antibacterial activity |
| EP1484304A1 (en) | 2003-05-28 | 2004-12-08 | Dainippon Ink And Chemicals, Inc. | Process for the preparation of fluorophenylalkylene acid derivatives |
| JP2008502689A (en) | 2004-06-15 | 2008-01-31 | グラクソ グループ リミテッド | Antibacterial agent |
| FR2872164B1 (en) * | 2004-06-29 | 2006-11-17 | Aventis Pharma Sa | QUINOLINE-4-SUBSTITUTED DERIVATIVES, PROCESS AND PREPARATION INTERMEDIATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| EP1771456A2 (en) | 2004-07-30 | 2007-04-11 | Palumed SA | Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| DE102004041163A1 (en) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | New compounds with antibacterial activity |
| JP4887297B2 (en) | 2004-09-24 | 2012-02-29 | アクテリオン ファーマシューティカルズ リミテッド | New bicyclic antibiotics |
| WO2006046552A1 (en) | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | Novel nitrogenous heterocyclic compounds and salts thereof |
| GB0426373D0 (en) | 2004-12-01 | 2005-01-05 | Syngenta Ltd | Fungicides |
| ES2351613T3 (en) | 2005-03-03 | 2011-02-08 | Santen Pharmaceutical Co., Ltd. | NEW CYCLIC COMPOUND THAT HAS A QUINOLILALQUILTIO GROUP. |
| US7842810B2 (en) | 2005-03-31 | 2010-11-30 | Janssen Pharmaceutica, Nv | Bicyclic pyrazole compounds as antibacterial agents |
| WO2007016610A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | Antibacterial agents |
| WO2007069555A1 (en) | 2005-12-12 | 2007-06-21 | Meiji Seika Kaisha, Ltd. | Novel 16-membered cyclic 4”-0-carbamoyl azalide derivative and process for producing same |
| CN101374831B (en) | 2006-01-26 | 2011-04-27 | 埃科特莱茵药品有限公司 | tetrahydropyran antibiotics |
-
2008
- 2008-04-09 CL CL200801003A patent/CL2008001003A1/en unknown
- 2008-04-10 JP JP2010502625A patent/JP5363457B2/en not_active Expired - Fee Related
- 2008-04-10 US US12/595,711 patent/US8114867B2/en not_active Expired - Fee Related
- 2008-04-10 CN CN200880011810.XA patent/CN101657450B/en not_active Expired - Fee Related
- 2008-04-10 ES ES08737784.2T patent/ES2560870T3/en active Active
- 2008-04-10 TW TW097113095A patent/TWI415614B/en not_active IP Right Cessation
- 2008-04-10 EP EP08737784.2A patent/EP2146987B1/en not_active Not-in-force
- 2008-04-10 AU AU2008238894A patent/AU2008238894B2/en not_active Ceased
- 2008-04-10 RU RU2009141310/04A patent/RU2506263C2/en not_active IP Right Cessation
- 2008-04-10 PL PL08737784T patent/PL2146987T3/en unknown
- 2008-04-10 AR ARP080101485A patent/AR066012A1/en unknown
- 2008-04-10 WO PCT/IB2008/051356 patent/WO2008126024A2/en not_active Ceased
- 2008-04-10 KR KR1020097023303A patent/KR101563752B1/en not_active Expired - Fee Related
- 2008-04-10 BR BRPI0809667-8A2A patent/BRPI0809667A2/en not_active IP Right Cessation
- 2008-04-10 MX MX2009010641A patent/MX2009010641A/en active IP Right Grant
- 2008-04-10 CA CA2679069A patent/CA2679069C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008238894A1 (en) | 2008-10-23 |
| CA2679069C (en) | 2016-06-07 |
| ES2560870T3 (en) | 2016-02-23 |
| JP2010523645A (en) | 2010-07-15 |
| TW200843780A (en) | 2008-11-16 |
| EP2146987B1 (en) | 2015-12-02 |
| US20100137290A1 (en) | 2010-06-03 |
| EP2146987A2 (en) | 2010-01-27 |
| MX2009010641A (en) | 2009-10-23 |
| AR066012A1 (en) | 2009-07-15 |
| WO2008126024A2 (en) | 2008-10-23 |
| CL2008001003A1 (en) | 2008-10-17 |
| CN101657450A (en) | 2010-02-24 |
| CA2679069A1 (en) | 2008-10-23 |
| JP5363457B2 (en) | 2013-12-11 |
| WO2008126024A3 (en) | 2008-12-04 |
| US8114867B2 (en) | 2012-02-14 |
| CN101657450B (en) | 2014-04-23 |
| PL2146987T3 (en) | 2016-05-31 |
| AU2008238894B2 (en) | 2013-06-20 |
| TWI415614B (en) | 2013-11-21 |
| KR20090130112A (en) | 2009-12-17 |
| RU2506263C2 (en) | 2014-02-10 |
| KR101563752B1 (en) | 2015-10-27 |
| RU2009141310A (en) | 2011-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0814593A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
| CY2024007I2 (en) | GLYCOPYRANOSYL SUBSTITUTED BENZONITRILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AND METHODS OF PREPARATION | |
| BRPI0717369A2 (en) | COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
| BRPI0821115A2 (en) | Aminotriazole-derived compound, drug, pharmaceutical composition and use of compound | |
| BRPI0917661A2 (en) | product containing macitentan, pharmaceutical composition containing it and use of macitentan | |
| BRPI0809977A2 (en) | USE OF A COMPOUND, COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING | |
| BRPI0907892A2 (en) | Azatricyclic antibiotic compound, medicine, pharmaceutical composition containing and use thereof | |
| BRPI0806531A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND. | |
| CL2008001003A1 (en) | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION. | |
| BRPI0815079A2 (en) | 1,2-DIAMIDE-ETHYLENE DERICTED COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THIS COMPOUND | |
| CL2007002916A1 (en) | COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS. | |
| BRPI0810696A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND | |
| CL2007002446A1 (en) | COMPOUNDS DERIVED FROM MORFOLINO PIRIMIDINA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO PRODUCE AN ANTIPROLIFERING EFFECT. | |
| BRPI0815190A2 (en) | Pyridine derivative compound, pharmaceutical composition comprising it and use thereof | |
| BRPI0809661A2 (en) | STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING PREGABALINE | |
| BRPI0921699A2 (en) | antioxidant complex, cosmetic and pharmaceutical compositions containing said complex and use of this complex | |
| BRPI0813587A2 (en) | COMPOUND, USE OF THE SAME, AND PHARMACEUTICAL COMPOSITION | |
| IL206562A0 (en) | Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition | |
| CR10229A (en) | DERIVATIVES OF 1,2,4,5, -TETRAHIDRO-3H-BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| BRPI0810399A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USING THEREOF | |
| EP2474522A4 (en) | AGOMÉLATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| BRPI0916571A2 (en) | alkylaminomethyloxazolidinone tricyclic derivative compound, medicament and pharmaceutical composition containing it and use of the compound | |
| BRPI0810019A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND | |
| BRPI0812942A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND | |
| BRPI0911772A2 (en) | compound, pharmaceutical composition, and use of the compound. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
| B25C | Requirement related to requested transfer of rights |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B25B | Requested transfer of rights rejected |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870170095261 DE 07/12/2017, DEVIDO AO DESPACHO PUBLICADO NA RPI 2529 DE 25/06/2019. |